Description-1 (Description 1)
Chemical structure of propofol showing a benzene ring with two isopropyl groups and a hydroxyl group attached.*
Propofol Injection, Emulsion
Product Images NDC 36000-058
5 FDA label images from Baxter Healthcare Corporation · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 36000-058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-2 (Figure 2)
A pharmacokinetic graph showing plasma propofol concentration (mcg/mL) versus minutes after end of infusion. The graph depicts recovery curves following 1 hour, 10 hour, and 10 day infusions, illustrating how plasma concentration decreases over time post-infusion, approaching levels associated with awakening.*
Container-3 (Container 3)
Propofol Injectable Emulsion, USP 10 mg/mL (200 mg per 20 mL) in a 20 mL single-dose vial for intravenous administration. Manufactured for Baxter Healthcare Corporation. Label includes handling instructions, storage conditions (store between 4°C to 25°C, do not freeze), and a barcode. The product is sterile and non-pyrogenic, emphasizing strict aseptic technique and discard within 12 hours of opening.*
Carton-4 (Carton 4)
Propofol Injectable Emulsion, USP 200 mg per 20 mL (10 mg per mL) intravenous injection in sterile, non-pyrogenic emulsion single-dose vials. Package contains 10 vials of 20 mL each. Label highlights the need to shake well before use and notes preservatives BHA and BHT. Manufactured by Baxter Healthcare Corporation.*
Carton-5 (Carton 5)
Propofol Injectable Emulsion, USP label for 200 mg per 20 mL (10 mg per mL) dosage strength. The label includes instructions for intravenous administration, aseptic technique, and shaking before use. It contains 10 single-dose vials of 20 mL each. The product is manufactured by Baxter Pharmaceuticals India Private Ltd and labeled for Baxter Healthcare Corporation, Deerfield, IL.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
